WaferGen Misses Deadline for Filing 10-Q | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – WaferGen BioSystems disclosed in a regulatory filing yesterday a delay in filing its second-quarter earnings report as it needs more time to sort through the financial effects of a private placement done in the spring.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Fast Company takes a look at startups in the nutrigenomic space that aim to offer personalized diet advice.

In a glamorous event, the Breakthrough Foundation gave out more than $25 million in prizes to researchers.

Immunotherapy might treat cancer, but it also appears to come with a risk of a number of side effects, the New York Times reports.

In PLOS this week: RNA-seq, ChIP-seq to determine metformin response; array-based approach to detect protozoa in blood; and more.